rs7254346

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000215.4(JAK3):​c.-36A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 1,036,266 control chromosomes in the GnomAD database, including 13,491 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 7265 hom., cov: 33)
Exomes 𝑓: 0.091 ( 6226 hom. )

Consequence

JAK3
NM_000215.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.861

Publications

17 publications found
Variant links:
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
  • T-B+ severe combined immunodeficiency due to JAK3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-17847968-T-C is Benign according to our data. Variant chr19-17847968-T-C is described in ClinVar as Benign. ClinVar VariationId is 328525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAK3NM_000215.4 linkc.-36A>G 5_prime_UTR_variant Exon 1 of 24 ENST00000458235.7 NP_000206.2 P52333-1A0A024R7M7
JAK3XR_007066796.1 linkn.15A>G non_coding_transcript_exon_variant Exon 1 of 20
JAK3NM_001440439.1 linkc.-67A>G 5_prime_UTR_variant Exon 1 of 24 NP_001427368.1
JAK3XM_011527991.3 linkc.-36A>G 5_prime_UTR_variant Exon 1 of 14 XP_011526293.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAK3ENST00000458235.7 linkc.-36A>G 5_prime_UTR_variant Exon 1 of 24 5 NM_000215.4 ENSP00000391676.1 P52333-1

Frequencies

GnomAD3 genomes
AF:
0.220
AC:
33472
AN:
152060
Hom.:
7242
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.561
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.221
Gnomad SAS
AF:
0.117
Gnomad FIN
AF:
0.0325
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0746
Gnomad OTH
AF:
0.193
GnomAD4 exome
AF:
0.0911
AC:
80578
AN:
884088
Hom.:
6226
Cov.:
29
AF XY:
0.0900
AC XY:
36732
AN XY:
408346
show subpopulations
African (AFR)
AF:
0.588
AC:
10447
AN:
17758
American (AMR)
AF:
0.120
AC:
283
AN:
2352
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
866
AN:
8322
East Asian (EAS)
AF:
0.212
AC:
2479
AN:
11688
South Asian (SAS)
AF:
0.113
AC:
1919
AN:
16958
European-Finnish (FIN)
AF:
0.0472
AC:
15
AN:
318
Middle Eastern (MID)
AF:
0.0919
AC:
318
AN:
3462
European-Non Finnish (NFE)
AF:
0.0763
AC:
60391
AN:
791666
Other (OTH)
AF:
0.122
AC:
3860
AN:
31564
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
3061
6122
9182
12243
15304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3218
6436
9654
12872
16090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.220
AC:
33553
AN:
152178
Hom.:
7265
Cov.:
33
AF XY:
0.217
AC XY:
16178
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.561
AC:
23298
AN:
41502
American (AMR)
AF:
0.149
AC:
2281
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
359
AN:
3472
East Asian (EAS)
AF:
0.222
AC:
1146
AN:
5168
South Asian (SAS)
AF:
0.117
AC:
565
AN:
4830
European-Finnish (FIN)
AF:
0.0325
AC:
345
AN:
10612
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0746
AC:
5071
AN:
68000
Other (OTH)
AF:
0.196
AC:
415
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
998
1996
2995
3993
4991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
3232
Bravo
AF:
0.243
Asia WGS
AF:
0.206
AC:
715
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. -

T-B+ severe combined immunodeficiency due to JAK3 deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
3.0
DANN
Benign
0.35
PhyloP100
-0.86
PromoterAI
-0.17
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7254346; hg19: chr19-17958777; API